Yi Liu

Design, synthesis, biological evaluation of benzoyl amide derivatives containing nitrogen heterocyclic ring as potential VEGFR-2 inhibitors.

Fa-Qian Shen, Han-Yue Qiu, Ze-Feng Wang, 2019, Bioorganic & medicinal chemistry.

Population pharmacokinetic models of anti-PD-1 mAbs in patients with multiple tumor types: A systematic review

Yufei Feng, Xiaolei Ren, Yi Liu, 2022, Frontiers in Immunology.

First-in-human study of KHK2455, a long-acting, potent and selective indoleamine 2,3-dioxygenase 1 (IDO-1) inhibitor, in combination with mogamulizumab (Moga), an anti-CCR4 monoclonal antibody, in patients (pts) with advanced solid tumors.

D. Hong, T. Yap, R. Latek, 2018 .